AN INTERNATIONAL OBSERVATIONAL STUDY TO ASSESS THE USE OF SORAFENIB AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): OPTIMIS

被引：1
作者：
Peck-Radosavljevic, M. [1 ]
Raoul, J. -L. [2 ]
Lee, H. C. [3 ]
Kudo, M. [4 ]
Nakajima, K. [5 ]
Cheng, A. -L. [6 ]
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
[2] Med Univ Vienna, Vienna, Austria
[3] Asan Med Ctr, Seoul, South Korea
[4] Kinki Univ, Sch Med, Osaka 589, Japan
[5] Bayer HealthCare Pharmaceut, Whippany, NJ USA
[6] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31517-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1338
引用
收藏
页码：S858 / S858
页数：1
相关论文
共 50 条
[21]   Trial Results for Sunitinib and Transarterial Chemoembolization (TACE) in Inoperable Hepatocellular Carcinoma (HCC) [J].
Wu, Y. V. ;
Tomaszewski, G. M. ;
Fetterly, G. J. ;
Kuvshinoff, B. ;
Groman, A. ;
Wilkinson, N. W. ;
Khushalani, N. I. ;
Iyer, R. V. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 :S114-S115
[22]   Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy [J].
Yao, Wang ;
Xue, Miao ;
Lu, Mingjian ;
Wang, Yu ;
Zhao, Yue ;
Wu, Yanqin ;
Fan, Wenzhe ;
Li, Jiaping .
FRONTIERS IN ONCOLOGY, 2020, 10
[23]   Transarterial chemoembolization (TACE) plus lenvatinib versus TACE plus sorafenib for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): A prospective randomized study [J].
Ding, X. ;
Sun, W. ;
Chen, J. ;
Li, W. ;
Shen, Y. ;
Guo, X. ;
Teng, Y. ;
Liu, X. ;
Li, W. .
ANNALS OF ONCOLOGY, 2020, 31 :S1306-S1306
[24]   Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study [J].
Ren, Baosheng ;
Wang, Wansheng ;
Shen, Jian ;
Li, Wanci ;
Ni, Caifang ;
Zhu, Xiaoli .
JOURNAL OF CANCER, 2019, 10 (05) :1189-1196
[25]   Transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma - a useful tool ? [J].
Meister, Tobias ;
Heinzow, Hauke ;
Lenz, Philipp ;
Ullerich, Hansjoerg ;
Domschke, Wolfram ;
Domagk, Dirk .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 :S129-S130
[26]   Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma [J].
Zhao, Shoujie ;
Dou, Weijia ;
Fan, Qingling ;
Hu, Jie ;
Li, Huichen ;
Zhang, Xiangnan ;
Zhang, Qian ;
Liu, Lei .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (09)
[27]   Stereotactic body radiotherapy (SBRT) as an alternative to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) [J].
Sapir, Eli ;
Tao, Yebin ;
Parikh, Neehar D. ;
Bazzi, Latifa ;
Devlin, Pauline ;
Novelli, Paula M. ;
Cuneo, Kyle Clifford ;
Lawrence, Theodore Steven ;
Schipper, Matthew J. ;
Feng, Mary .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[28]   Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma (HCC) undergoing Transarterial Chemoembolization (TACE) [J].
McNally, M. E. ;
Martinez, A. ;
Malhotra, L. ;
Bloomston, M. ;
Schmidt, C. R. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 :S33-S33
[29]   Transarterial chemoembolization (TACE) with doxorubicin eluting beads (DEB) for the treatment of hepatocellular carcinoma (HCC) [J].
Vit, A. ;
De Pauli, F. ;
Sponza, M. ;
Mazzer, M. ;
Foltran, L. ;
Montanari, M. ;
Piccoli, G. ;
Fasola, G. ;
Gasparini, D. ;
Aprile, G. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[30]   Doxorubicin eluting bead (DEB) transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma (HCC) [J].
De Pauli, Federica ;
Vit, Alessandro ;
Aprile, Giuseppe ;
Sponza, Massimo ;
Iaiza, Emiliana ;
Zanon, Elisa ;
Piccoli, Gianluca ;
Marzio, Andrea ;
Giovannoni, Mariella ;
Fasola, Gianpiero ;
Gasparini, Daniele .
ANNALS OF ONCOLOGY, 2007, 18 :9-9
12345